Sold
Details
OPPORTUNITY
Offering a game changing, non-invasive diagnostic platform technology which saves lives through higher accuracy, faster results, and improved patient experience.
-
KEY HIGHLIGHTS
- Established 2004
- Current patient trials underway at major NHS Hospitals throughout the UK
- Large patent portfolio across the world, with further pending
- Clinical Trial Partners in the US engaged and supportive
- Includes the IPR for a specialised cell concentration & preservation collection device, a clinically validated Biomarker and utilises AI for automated analysis of results
- 2MIllion Euro + £4.4M Investment to 2020
- Initial core technology as a result of a £12million pound research project funded by Cancer Research UK and Cambridge University.
- Historic Valuation of business at circa £8 Million
Please download Notice For Sale for further information
Viewing Details
EXPRESSIONS OF INTEREST
- Interested parties will be required to sign a nondisclosure agreement (NDA) before further information is
- Expressions of interest are required by 12noon on Friday 12th August 2022 together with proof of funding with completion as soon possible
REQUESTS FOR AN NDA SHOULD BE SENT TO :-
RICHARD TEMPLE ([email protected])
0113 209 1052
or
ABBIE HICKMAN ([email protected])
0114 551 2527
Location
Aberdeen, Scotland
Status
Sold
Method
Business for Sale
Bidding ends
Ref
Project Cell
Category
Business & Trading Assets
Call +44 (0)345 130 3332 to request a viewing